UROCIT-K

This brand name is authorized in Austria, Canada, Ecuador, Estonia, Hong Kong, Israel, Singapore, Turkey, United States, South Africa

Active ingredients

The drug UROCIT-K contains one active pharmaceutical ingredient (API):

1 Potassium citrate UNII EE90ONI6FF - POTASSIUM CITRATE

Citrate and citric acid solutions are systematic and urinary alkalinizers thereby providing symptomatic relief of dysuria. Read about Potassium citrate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
UROCIT-K Tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A12BA02	Potassium citrate	A Alimentary tract and metabolism → A12 Mineral supplements → A12B Potassium → A12BA Potassium
Discover more medicines within A12BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 01914022, 02353997
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 27.514-02-07
Country: EE	Ravimiamet	Identifier(s): 1800469
Country: HK	Department of Health Drug Office	Identifier(s): 47513
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7919
Country: SG	Health Sciences Authority	Identifier(s): 08734P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699771010015, 8699771030020
Country: US	FDA, National Drug Code	Identifier(s): 0178-0600, 0178-0610, 0178-0615
Country: ZA	Health Products Regulatory Authority	Identifier(s): 49/18.3/0005